{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:20:32Z","timestamp":1790835632798,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115565"],"award-info":[{"award-number":["115565"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pathogenesis and aetiology of systemic sclerosis (SSc) are currently unclear, thus rendering disease prognosis, diagnosis and treatment challenging. The aim of this study was to use paired skin biopsy samples from affected and unaffected areas of the same patient, in order to compare the proteomes and identify biomarkers and pathways which are associated with SSc pathogenesis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Biopsies were obtained from affected and unaffected skin areas of SSc patients. Samples were cryo-pulverised and proteins were extracted and analysed using mass spectrometry (MS) discovery analysis. Differentially expressed proteins were revealed after analysis with the Progenesis QIp software. Pathway analysis was performed using the Enrichr Web server. Using specific criteria, fifteen proteins were selected for further validation with targeted-MS analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Proteomic analysis led to the identification and quantification of approximately 2000 non-redundant proteins. Statistical analysis showed that 169 of these proteins were significantly differentially expressed in affected versus unaffected tissues. Pathway analyses showed that these proteins are involved in multiple pathways that are associated with autoimmune diseases (AIDs) and fibrosis. Fifteen of these proteins were further investigated using targeted-MS approaches, and five of them were confirmed to be significantly differentially expressed in SSc affected versus unaffected skin biopsies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Using MS-based proteomics analysis of human skin biopsies from patients with SSc, we identified a number of proteins and pathways that might be involved in SSc progression and pathogenesis. Fifteen of these proteins were further validated, and results suggest that five of them may serve as potential biomarkers for SSc.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-020-02196-x","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T12:02:57Z","timestamp":1588852977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparative analysis of affected and unaffected areas of systemic sclerosis skin biopsies by high-throughput proteomic approaches"],"prefix":"10.1186","volume":"22","author":[{"given":"Paraskevi","family":"Chairta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paschalis","family":"Nicolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kleitos","family":"Sokratous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Galant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Houssiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasis","family":"Oulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George M.","family":"Spyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta E.","family":"Alarcon-Riquelme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard R.","family":"Lauwerys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0622-7594","authenticated-orcid":false,"given":"Kyproula","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,7]]},"reference":[{"issue":"3","key":"2196_CR1","doi-asserted-by":"publisher","first-page":"e17551-e","DOI":"10.1371\/journal.pone.0017551","volume":"6","author":"C Nguyen","year":"2011","unstructured":"Nguyen C, B\u00e9rezn\u00e9 A, Baubet T, Mestre-Stanislas C, Rannou F, Papelard A, et al. Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis. PloS one. 2011;6(3):e17551-e.","journal-title":"PloS one"},{"issue":"7","key":"2196_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1371\/journal.pgen.1002178","volume":"7","author":"O Gorlova","year":"2011","unstructured":"Gorlova O, Martin JE, Rueda B, Koeleman BP, Ying J, Teruel M, et al. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet. 2011;7(7):14.","journal-title":"PLoS Genet"},{"issue":"1","key":"2196_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/MAJ.0b013e3182a55d24","volume":"347","author":"LA Saketkoo","year":"2014","unstructured":"Saketkoo LA, Magnus JH, Doyle MK. The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope. Am J Med Sci. 2014;347(1):54\u201363.","journal-title":"Am J Med Sci"},{"issue":"15002","key":"2196_CR4","first-page":"2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, et al. Systemic sclerosis. Nat Rev Dis Primers. 2015;1(15002):2.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"2196_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/ar628","volume":"5","author":"KT Ho","year":"2003","unstructured":"Ho KT, Reveille JD. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther. 2003;5(2):80\u201393 Epub 2003\/02\/12.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"2196_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.humimm.2016.10.017","volume":"78","author":"P Chairta","year":"2017","unstructured":"Chairta P, Nicolaou P, Christodoulou K. Genomic and genetic studies of systemic sclerosis: a systematic review. Hum Immunol. 2017;78(2):153\u201365.","journal-title":"Hum Immunol"},{"issue":"5","key":"2196_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3109\/1354750X.2014.920046","volume":"19","author":"P Balanescu","year":"2014","unstructured":"Balanescu P, Ladaru A, Balanescu E, Baicus C, Dan GA. Systemic sclerosis biomarkers discovered using mass-spectrometry-based proteomics: a systematic review. Biomarkers. 2014;19(5):345\u201355.","journal-title":"Biomarkers."},{"issue":"7","key":"2196_CR8","first-page":"1573","volume":"28","author":"EC LeRoy","year":"2001","unstructured":"LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28(7):1573\u20136.","journal-title":"J Rheumatol"},{"issue":"4","key":"2196_CR9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/rheumatology\/key401","volume":"58","author":"C Galant","year":"2019","unstructured":"Galant C, Marchandise J, Stoenoiu MS, Ducreux J, De Groof A, Pirenne S, et al. Overexpression of ubiquitin-specific peptidase 15 in systemic sclerosis fibroblasts increases response to transforming growth factor \u03b2. Rheumatology. 2019;58(4):708\u201318.","journal-title":"Rheumatology."},{"key":"2196_CR10","doi-asserted-by":"crossref","unstructured":"Potriquet J, Laohaviroj M, Bethony JM, Mulvenna J. A modified FASP protocol for high-throughput preparation of protein samples for mass spectrometry. PloS one. 2017;12(7):e0175967.","DOI":"10.1371\/journal.pone.0175967"},{"issue":"2","key":"2196_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nmeth.2767","volume":"11","author":"U Distler","year":"2014","unstructured":"Distler U, Kuharev J, Navarro P, Levin Y, Schild H, Tenzer S. Drift time-specific collision energies enable deep-coverage data-independent acquisition proteomics. Nat Methods. 2014;11(2):167\u201370.","journal-title":"Nat Methods"},{"issue":"6","key":"2196_CR12","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1002\/pmic.200800562","volume":"9","author":"SJ Geromanos","year":"2009","unstructured":"Geromanos SJ, Vissers JP, Silva JC, Dorschel CA, Li GZ, Gorenstein MV, et al. The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS\/MS. Proteomics. 2009;9(6):1683\u201395.","journal-title":"Proteomics."},{"issue":"7","key":"2196_CR13","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B MacLean","year":"2010","unstructured":"MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics. 2010;26(7):966\u20138.","journal-title":"Bioinformatics."},{"issue":"3","key":"2196_CR14","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1006\/bbrc.1998.9532","volume":"251","author":"H Wada","year":"1998","unstructured":"Wada H, Kito K, Caskey LS, Yeh ET, Kamitani T. Cleavage of the C-terminus of NEDD8 by UCH-L3. Biochem Biophys Res Commun. 1998;251(3):688\u201392.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2196_CR15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.yexcr.2012.11.016","volume":"319","author":"J Jandova","year":"2013","unstructured":"Jandova J, Janda J, Sligh JE. Cyclophilin 40 alters UVA-induced apoptosis and mitochondrial ROS generation in keratinocytes. Exp Cell Res. 2013;319(5):750\u201360 Epub 2012\/12\/03.","journal-title":"Exp Cell Res"},{"issue":"3","key":"2196_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/cvr\/cvv096","volume":"106","author":"GL Perrucci","year":"2015","unstructured":"Perrucci GL, Gowran A, Zanobini M, Capogrossi MC, Pompilio G, Nigro P. Peptidyl-prolyl isomerases: a full cast of critical actors in cardiovascular diseases. Cardiovasc Res. 2015;106(3):353\u201364.","journal-title":"Cardiovasc Res"},{"issue":"15","key":"2196_CR17","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.1093\/nar\/gkl468","volume":"34","author":"P Linder","year":"2006","unstructured":"Linder P. Dead-box proteins: a family affair--active and passive players in RNP-remodeling. Nucleic Acids Res. 2006;34(15):4168\u201380.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2196_CR18","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.ajhg.2008.05.002","volume":"82","author":"V Massa","year":"2008","unstructured":"Massa V, Fernandez-Vizarra E, Alshahwan S, Bakhsh E, Goffrini P, Ferrero I, et al. Severe infantile encephalomyopathy caused by a mutation in COX6B1, a nucleus-encoded subunit of cytochrome c oxidase. Am J Hum Genet. 2008;82(6):1281\u20139 Epub 2008\/05\/30.","journal-title":"Am J Hum Genet"},{"issue":"6461","key":"2196_CR19","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/367338a0","volume":"367","author":"J Emsley","year":"1994","unstructured":"Emsley J, White HE, O'Hara BP, Oliva G, Srinivasan N, Tickle IJ, et al. Structure of pentameric human serum amyloid P component. Nature. 1994;367(6461):338\u201345.","journal-title":"Nature."},{"issue":"1","key":"2196_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/0952-7915(95)80029-8","volume":"7","author":"H Gewurz","year":"1995","unstructured":"Gewurz H, Zhang XH, Lint TF. Structure and function of the pentraxins. Curr Opin Immunol. 1995;7(1):54\u201364.","journal-title":"Curr Opin Immunol"},{"key":"2196_CR21","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","volume":"6","author":"D Pattanaik","year":"2015","unstructured":"Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE. Pathogenesis of systemic sclerosis. Front Immunol. 2015;6:272.","journal-title":"Front Immunol"},{"issue":"1","key":"2196_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3899\/jrheum.160736","volume":"44","author":"C Corallo","year":"2017","unstructured":"Corallo C, Santucci A, Bernardini G, Figura N, Leoncini R, Riolo G, et al. Proteomic investigation of dermal fibroblasts isolated from affected and unaffected skin samples from patients with limited cutaneous systemic sclerosis: 2 distinct entities? J Rheumatol. 2017;44(1):40\u20138.","journal-title":"J Rheumatol"},{"issue":"3","key":"2196_CR23","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/art.20962","volume":"52","author":"M Chen","year":"2005","unstructured":"Chen M, Dittmann A, Kuhn A, Ruzicka T, von Mikecz A. Recruitment of topoisomerase I (Scl-70) to nucleoplasmic proteasomes in response to xenobiotics suggests a role for altered antigen processing in scleroderma. Arthritis Rheum. 2005;52(3):877\u201384.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2196_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13075-016-1168-x","volume":"18","author":"M Okr\u00f3j","year":"2016","unstructured":"Okr\u00f3j M, Johansson M, Saxne T, Blom AM, Hesselstrand R. Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis. Arthritis Res Ther. 2016;18(1):267.","journal-title":"Arthritis Res Ther"},{"key":"2196_CR25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fimmu.2012.00160","volume":"3","author":"GA Ramirez","year":"2012","unstructured":"Ramirez GA, Franchini S, Rovere-Querini P, Sabbadini MG, Manfredi AA, Maugeri N. The role of platelets in the pathogenesis of systemic sclerosis. Front Immunol. 2012;3:160.","journal-title":"Front Immunol"},{"issue":"2","key":"2196_CR26","first-page":"183","volume":"45","author":"I Agache","year":"2007","unstructured":"Agache I, Radoi M, Duca L. Platelet activation in patients with systemic scleroderma--pattern and significance. Rom J Intern Med. 2007;45(2):183\u201391.","journal-title":"Rom J Intern Med"},{"issue":"5","key":"2196_CR27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/ard.2002.004838","volume":"63","author":"GH Stummvoll","year":"2004","unstructured":"Stummvoll GH, Aringer M, Grisar J, Steiner CW, Smolen JS, Knobler R, et al. Increased transendothelial migration of scleroderma lymphocytes. Ann Rheum Dis. 2004;63(5):569\u201374.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2196_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/ar2002","volume":"8","author":"B Giusti","year":"2006","unstructured":"Giusti B, Fibbi G, Margheri F, Serrati S, Rossi L, Poggi F, et al. A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients. Arthritis Res Ther. 2006;8(4):19.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"2196_CR29","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/art.22694","volume":"56","author":"GA Tennent","year":"2007","unstructured":"Tennent GA, Dziadzio M, Triantafillidou E, Davies P, Gallimore JR, Denton CP, et al. Normal circulating serum amyloid P component concentration in systemic sclerosis. Arthritis Rheum. 2007;56(6):2013\u20137.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"2196_CR30","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/rheumatology\/ken370","volume":"47","author":"N Aden","year":"2008","unstructured":"Aden N, Shiwen X, Aden D, Black C, Nuttall A, Denton CP, et al. Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer. Rheumatology. 2008;47(12):1754\u201360.","journal-title":"Rheumatology."},{"issue":"6","key":"2196_CR31","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/9544","volume":"5","author":"MC Bickerstaff","year":"1999","unstructured":"Bickerstaff MC, Botto M, Hutchinson WL, Herbert J, Tennent GA, Bybee A, et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med. 1999;5(6):694\u20137.","journal-title":"Nat Med"},{"issue":"4","key":"2196_CR32","doi-asserted-by":"publisher","first-page":"L603","DOI":"10.1152\/ajplung.00530.2007","volume":"295","author":"GS Bogatkevich","year":"2008","unstructured":"Bogatkevich GS, Ludwicka-Bradley A, Singleton CB, Bethard JR, Silver RM. Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration. Am J Physiol Lung Cell Mol Physiol. 2008;295(4):L603\u2013L11 Epub 2008\/08\/01.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"2196_CR33","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.2353\/ajpath.2010.091095","volume":"177","author":"F Del Galdo","year":"2010","unstructured":"Del Galdo F, Shaw MA, Jimenez SA. Proteomic analysis identification of a pattern of shared alterations in the secretome of dermal fibroblasts from systemic sclerosis and nephrogenic systemic fibrosis. Am J Pathol. 2010;177(4):1638\u201346 Epub 2010\/08\/19.","journal-title":"Am J Pathol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02196-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-020-02196-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02196-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T23:39:26Z","timestamp":1620344366000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-020-02196-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2196"],"URL":"https:\/\/doi.org\/10.1186\/s13075-020-02196-x","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,7]]},"assertion":[{"value":"14 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethical Committee of Universit\u00e9 catholique de Louvain (2014\/17DEC\/603) and the Cyprus National Bioethics committee (\u0395\u0395\u0392\u039a\/\u0395\u03a0\/2015\/31) and conducted in accordance with the 1964 Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}